Posts tagged private placement
OnDosis completes a private placement of SEK 92 million led by Aeternum Capital
OnDosis completes a private placement of SEK 92 million led by Aeternum Capital

OnDosis, a Swedish Life science company developing a new device technology platform, announced today that the Company has completed a pre-IPO private placement of SEK 92 million. Investors in the private placement include Aeternum Capital, DIG Investment and Albonja.

Read More
PressreleaseMelisha LinnellMartin Olovsson, digital therapeutics, OnDosis, ​Tiefenbacher Group, Life Science, Aeternum Management, Danske Bank, Staffan Ternström, personalised medicine, private placement